Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drug shares slide into red, but AstraZeneca climbs
Marketwatch
Monday, September 22, 2008 - 4:20pm
tags:
A Closer Look at La Jolla’s Riquent
Cafepharma Detailpiece
Monday, September 22, 2008 - 10:48am
tags:
Cash-poor patients cut back on meds
Fierce Pharma
Monday, September 22, 2008 - 10:47am
tags:
Novartis eyes MediGene's cancer drug - sources
Hemscott, UK
Monday, September 22, 2008 - 10:45am
tags:
Decision due soon on Lilly, Daiichi blood thinner
Guardian, UK
Monday, September 22, 2008 - 10:45am
tags:
WHO concerned over plant of Novartis unit Sandoz
Forbes
Monday, September 22, 2008 - 10:44am
tags:
Strong data for Amgen's denosumab excites doctors
Pharma Times, UK
Monday, September 22, 2008 - 10:44am
tags:
Biolase: Is Turnaround Under Threat?
Seeking Alpha
Monday, September 22, 2008 - 10:43am
tags:
SciClone Provides Promising Results From Its Phase 2A Clinical Trial Using SCV-07 as a Monotherapy in Patients With Chronic Hepatitis C Infection
Yahoo
Monday, September 22, 2008 - 10:42am
tags:
Alpharma Licenses Durect's Novel Bupivacaine Patch
Yahoo
Monday, September 22, 2008 - 9:59am
tags:
Safe Havens in Large-Cap Pharma
Yahoo/Zacks.com
Monday, September 22, 2008 - 9:06am
tags:
FDA Meeting Provides Green Light for Cell Therapeutics Submission of Supplemental Filing for Zevalin(R) Label Expansion
Yahoo
Monday, September 22, 2008 - 9:05am
tags:
Sanofi Clinches Zentiva Takeover With Sweeter $2.6 Billion Bid
Bloomberg
Monday, September 22, 2008 - 9:04am
tags:
Merck KGaA's New Rebif Formulation Helps Prevent Brain Damage
Bloomberg
Monday, September 22, 2008 - 9:04am
tags:
FDA issues complete response letter to Roche for Actemra Biologics License Application
PipeLineReview
Sunday, September 21, 2008 - 4:55pm
tags:
Decision due soon on Lilly, Daiichi blood thinner
Reuters
Sunday, September 21, 2008 - 4:54pm
tags:
Teva: MS drugs continue to prove safe, effective
Globes, Israel
Sunday, September 21, 2008 - 4:52pm
tags:
Expert Says Eshoo-Barton Bill Stifles Drug Innovation, USA
Medical News Today
Sunday, September 21, 2008 - 4:50pm
tags:
More consolidation seen in generic drug industry
Chicago Daily Herald, IL
Sunday, September 21, 2008 - 4:48pm
tags:
Med Tech May Offer Investors Refuge
Yahoo
Saturday, September 20, 2008 - 11:59am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.